Peer Review History
| Original SubmissionMarch 20, 2023 |
|---|
|
PONE-D-23-07658Impact of COVID-19 on antenatal care provision at public hospitals in Ethiopia: a mixed method studyPLOS ONE Dear Dr. Kassa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Major revision of your manuscriptis require before further consideration. Psy atten to reviewer 2 comments and make appropriate corrections. Please submit your revised manuscript by Jul 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ephraim Kumi Senkyire Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the good work. 1. the first theme is described as "the impact of ANC access"........I hope it is a typing error and better to write it as" access to ANC or the impact of COVID-19 on ANC access...." 2. please remove the last row in Table 3(Joint display of quantitative, qualitative and mixed methods results ...) Reviewer #2: Comments Thank you for your invitation to review this paper. Here are comments listed below: Title The study is already over searched, Even a systematic review of metanalaysis have been done in Ethiopia entitled with <impact a="" and="" covid-19="" essential="" ethiopia:="" healthcare="" in="" maternal="" metaanalysis="" of="" on="" pandemic="" review="" services="" systematic="" utilization=""> or link https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281260#:~:text=Impact%20of%20COVID%2D19%20pandemic%20on%20ANC%20services,CI%3A%2015.85%2C%2022.76) . So what you added to your finding? The title should be rewrite in SMART form meaning that mainly it should clear where (specifically for local reader better to add < Sidam Region, Ethiopia> and when the study done. Abstract Methods section What is the exact data collection period? What is your sample size? It is not clear to the reader. The author collect data before covid 19 (March 2019 to February 2020), so how to relate the study with covid 19? Result No information mentioned about the quantitative data in your result. So please include them. Conclusion Authors should be selective to generalize the whole finding what they have gotten from the finding. It is not clear that why the authors select only three views (ANC access, uptake and provision) for conclusion? Keywords The author should select MESH terms for key word selection. Introduction The first sentence needs citation–page 2, line49-50 Please avoid the use of reference repeatedly. E.g. reference 1, 3, etc. repeated more than two times. Page 3 line 69, insert citation of reference (9) at the end of sentence. Methods Please Rewrite as <methods and="" materials=""> Setting All information presented here are mentioned in the methods section. So please try to merge it or delete one them since in scientific paper writing form no need of redundancy. What are your study settings/institutions? It is not clearly stated, and try to focus on your study area and selected settings. Quantitative methods Setting Please rewrite the whole paragraph of this section. No need of writing unnecessary information in study setting like the first sentence you wrote about study design <we an="" implemented="" interrupted="" series="" time="">. Sample size not determined. Why? Data processing and analysis It lacks focus. It should describe about data entry and analysis, but not data collection methods, data collection procedures etc. Qualitative methods Please omit redundancy. Your method part is not clear as a whole. You have three section methods in this document (methods, quantitative methods, and Qualitative methods). You should have one comprehensive methods or a max of two sections of methods. Study participant recruitment and sampling technique Who is your research assistant? Please clearly mentioned them What are your study participants? Patient or health care provider Why the authors used a purposive sampling technique? Is that good to use non probable sampling methods to write scientific papers important for scientific evidence? In my view it is not acceptable. Please insert this sentence in <participants being="" consent="" informed="" interviewed="" prior="" provided="" to="" written=""> in Ethical approval and consent section. What about Study participant recruitment and sampling technique of quantitative methods?? Data collection tools and procedure No information mentioned here that describe about the data collection instrument/ tool you used in measurable way. Where the questionnaire you adapted or adopted? Is the too you used is valid or not? If valid what is its validity and reliability test value? Data processing and analysis It seems only qualitative study design study. What about Data processing and analysis of quantitative section? Results Trends in antenatal care provision in fifteen hospitals Where you have got IRR 1.1%? Please revise it (1%). Line 227 Qualitative results Please rewrite the participants’ response in quotation form. Where is the result of the quantitative part? You have mentioned only the qualitative and joint result. Please add the missed section. Discussion Try to discuss both the quantitative and qualitative findings. Please revise and rewrite in two side comparative form. Conclusion Replaced conclusion with < conclusions and recommendations> Try to focus on your finding e.g. You recommended <additional are="" country="" factors="" impact="" in="" long-term="" needed="" on="" ongoing="" studies="" the="" these="" to="" understand="" war="">. It is out of your scope of study/title. As a whole please try to contact English language expertise and revise the grammar, punctuation, syntax etc. of the entire document to be clear, easily understandable to the readers.</additional></participants></we></methods></impact> ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-23-07658R1 Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods study PLOS ONE Dear Dr. Kassa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Kind regards, Ephraim Kumi Senkyire Academic Editor PLOS ONE Additional Editor Comments: Thank you for considering PLOSONE. Base on reviewer 2 detailed comments to refined your manuscript to meet the quality of mix-study, after careful cross-check with your response, most of the comment were not taken into consideration. e.g you claimed the study is a mixed method however, you failed to report or discuss the quantitative aspect of the study. this is one of the several vital comment you refused to address hence your manuscript can not be accepted in this journal. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] - - - - - For journal use only: PONEDEC3 |
| Revision 2 |
|
PONE-D-23-07658R2Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods studyPLOS ONE Dear Dr. Kassa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by 27 Feb 2024. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fekede Asefa Kumsa, PhD Academic Editor PLOS ONE Journal Requirements: Additional Editor Comments (if provided): One of the significant issues in this manuscript is a lack of focus and idea fragmentation. In the findings section, similar ideas and quotes appear in multiple places. For instance, the community's perception of health facilities as the epicenter of COVID-19 infection is displayed at various points under different themes or sub-themes. The same issue arises with transportation-related issues. There is a misalignment between some themes/subthemes and the provided descriptions. For example, in the sub-theme 'Community discrimination against women attending hospital,' the description addresses both community discrimination against women and care providers while the subtheme is about women. It is crucial for the theme/subtheme and the description to align cohesively. The finding section benefit from proper resynthesis. Additionally, the manuscript focuses on the impact of COVID-19 on antenatal care provision. However, unrelated issues regarding vaccine hesitancy are introduced in the findings section without proper context. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: No Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: I Don't Know Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: No Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Reviewer comments Manuscript Number: PONE-D-23-07658R2 Full Title: Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods study Generally, the manuscript need thorough English language edition. The punctuation and grammar need correction to facilitate easy understanding for readers. Title: Is effect or impact appropriate term to indicate results of covid-19 during mentioned times (six months, March to August 2020). This times as authors may remember was when there were complete to partial closure of services (the government declared a five-month national state of emergency starting April 8th, 2020), it was not time when services put in to place or cease of closure. Abstract Background: what was study gaps that authors want to uncover? Method: Did authors calculate minimum sample size? How authors selected these facilities and participants? How authors maintained data quality? How quantitative data were reported? Result: line 37 and 38, the sentence is not clear. Was the effect of covid-19 significant? Line 41 subtheme ‘COVID-19 vaccine hesitancy’ was identified by authors. Was there a vaccine during specified time? I recommend these subthemes categorized under their themes, so that effect of covid-19 seen boldly. Conclusion and recommendation: is qualitative or quantitative result support this conclusion? Or both? Authors did not indicate adequate finding that support their conclusion in result part of the abstract. Are your recommendation supported by your evidence and updated? What is the study implication? Introduction Authors did not indicate study gaps, why this study is needed. What is the significance of this study? Why qualitative study needed? What is the objective of qualitative study? Method Line 100 what specific design was used for quantitative study? How about qualitative study? These two terms are broad terms to describe design, authors need to explain specific design they employed for both type of study. Line 107, rewrite the subtitle. ‘Data collection method for quantitative data’ The content should also clearly indicate the tool used, who collected and how you collected the data. Collection tools and procedure for qualitative data How authors interviewed those who have difficulties in speaking official language? Authors failed to explain how they assured quality of data for both quantitative and qualitative methods. Result How many was the response rate? Was there any missing data? How it was managed? Change the following subtitle ‘Qualitative results’ to appropriate subtopic. Check its content and choose. The authors are not expected to write ‘quote’ for each paragraphs. Too many quote indicate poor analysis of the data. Discussion Authors should focus on the major findings. This discussion is not easy to understand and focused. Conclusion Is the disruption is still there? Authors should cautiously conclude and recommend based on their findings. It may contribute to knowledge of what happened during covid-19. Otherwise, I don’t think this conditions are still there in Sidama. Reviewer #4: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 3 |
|
PONE-D-23-07658R3Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods studyPLOS ONE Dear Dr. Kassa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fekede Asefa Kumsa, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear authors, Thank you for addressing most of the the reviewers comments. There still some minor issues need to be addressed. 1. I would suggest the authors work on the abstract section to make it more appealing, especially the result section. The second sentence of the conclusion and recommendation section seems better fit into the result section and please move it up. Please don't introduce an abbreviation in the abstract if you are not gong to use it in this section. e.g., HMIS. Your abbreviation use is actually inconsistent throughout the document. For some, you provided multiple full text description (e.g., WHO), while for some others, you started using it without providing a full text discerption at the first use (e.g., ANC). Please make sure your abbreviations use is consistent and follows the standard. 2. In the abstract section, you stated that you collected 12 months' data before the occurrence of COVID-19, while in the method section it says 18 months data were collected. Please make sure you are consistent. In addition, please also discuss the appropriateness of comparing 12 or 18 months data (before COVID-19) with 6 months data (during COVID-19). 3. Please move table 2 to supplementary file. 4. Under the community discrimination against those attending the hospital sub-theme, you clearly discussed about the community discrimination against those attending the hospital. However, you gave little emphases on its link to the access to ANC. You have tried to say a few things in a second sentence of this section, but didn't substantiate it with the data from the participants. Please clearly show the link of this sub-theme to the access to ANC by substantiating it with the data. 5. Neither your discerption nor the provided quate still doesn't show the influence of COVID-19 vaccine hesitancy on ANC service utilization. You have tried to respond on the response letter, but the description should appear on the manuscript too. Please make sure that this claim is substantiated with evidence came from the participants. It shouldn't be the authors speculation. Best regards, [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 4 |
|
Impact of COVID-19 on antenatal care provision at public hospitals in Sidama region, Ethiopia: a mixed methods study PONE-D-23-07658R4 Dear Dr. Kassa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fekede Asefa Kumsa, PhD Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-23-07658R4 PLOS ONE Dear Dr. Kassa, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fekede Asefa Kumsa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .